Brind.
  1. Tilray launched products through licensed retailers in Canada on May 28, 2026.
  2. Tilray, a company based in Canada, has begun exporting medical-grade cannabis products to markets in Europe.
  3. Tilray secured a partnership to distribute medical cannabis products in Italy, while Trump's administration considers reclassifying cannabis.
  4. Trump's administration is looking to reclassify marijuana, which could reshape the pot industry, involving Aurora Cannabis and TD Cowen.

An executive order has been pushed for the expeditious reclassification of Canopy Growth.

1 report, 1 independent Updated Jul 25
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

An executive order has been pushed for the expeditious reclassification of Canopy Growth.

Who's involved

What this event is mainly about
Donald Trump

Keep exploring

Part of

Trump's administration is looking to reclassify marijuana, which could reshape the pot industry, involving Aurora Cannabis and TD Cowen. All 2 developments

Within Tilray launched products through licensed retailers in Canada on May 28, 2026.

The entities involved

Coverage

Newest first; wire copies grouped
  • fool.comThinking About Buying Canopy Growth? You May Want to Wait for This 1 Thing to Happen First. | The Motley Fool